155 related articles for article (PubMed ID: 38036070)
1. Development of tandem antigen capture ELISAs measuring QSOX1 isoforms in plasma and serum.
Koelbel C; Ruiz Y; Wan Z; Wang S; Ho T; Lake D
Free Radic Biol Med; 2024 Jan; 210():212-220. PubMed ID: 38036070
[TBL] [Abstract][Full Text] [Related]
2. Disulfide bond generation in mammalian blood serum: detection and purification of quiescin-sulfhydryl oxidase.
Israel BA; Jiang L; Gannon SA; Thorpe C
Free Radic Biol Med; 2014 Apr; 69():129-35. PubMed ID: 24468475
[TBL] [Abstract][Full Text] [Related]
3. An inhibitory antibody blocks the first step in the dithiol/disulfide relay mechanism of the enzyme QSOX1.
Grossman I; Alon A; Ilani T; Fass D
J Mol Biol; 2013 Nov; 425(22):4366-78. PubMed ID: 23867277
[TBL] [Abstract][Full Text] [Related]
4. Quiescin sulfhydryl oxidase 1 promotes invasion of pancreatic tumor cells mediated by matrix metalloproteinases.
Katchman BA; Antwi K; Hostetter G; Demeure MJ; Watanabe A; Decker GA; Miller LJ; Von Hoff DD; Lake DF
Mol Cancer Res; 2011 Dec; 9(12):1621-31. PubMed ID: 21989104
[TBL] [Abstract][Full Text] [Related]
5. Development of a new monoclonal antibody to ovine chimeric IgE and its detection of systemic and local IgE antibody responses to the intestinal nematode Trichostrongylus colubriformis.
Bendixsen T; Windon RG; Huntley JF; MacKellar A; Davey RJ; McClure SJ; Emery DL
Vet Immunol Immunopathol; 2004 Jan; 97(1-2):11-24. PubMed ID: 14700534
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-32 monoclonal antibodies for immunohistochemistry, Western blotting, and ELISA.
Kim KH; Shim JH; Seo EH; Cho MC; Kang JW; Kim SH; Yu DY; Song EY; Lee HG; Sohn JH; Kim J; Dinarello CA; Yoon DY
J Immunol Methods; 2008 Apr; 333(1-2):38-50. PubMed ID: 18252253
[TBL] [Abstract][Full Text] [Related]
7. Quiescin Sulfhydryl Oxidase 1 (QSOX1) Secreted by Lung Cancer Cells Promotes Cancer Metastasis.
Sung HJ; Ahn JM; Yoon YH; Na SS; Choi YJ; Kim YI; Lee SY; Lee EB; Cho S; Cho JY
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30336636
[TBL] [Abstract][Full Text] [Related]
8. Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer.
Katchman BA; Ocal IT; Cunliffe HE; Chang YH; Hostetter G; Watanabe A; LoBello J; Lake DF
Breast Cancer Res; 2013 Mar; 15(2):R28. PubMed ID: 23536962
[TBL] [Abstract][Full Text] [Related]
9. Unbiased plasma proteomics for novel diagnostic biomarkers in cardiovascular disease: identification of quiescin Q6 as a candidate biomarker of acutely decompensated heart failure.
Mebazaa A; Vanpoucke G; Thomas G; Verleysen K; Cohen-Solal A; Vanderheyden M; Bartunek J; Mueller C; Launay JM; Van Landuyt N; D'Hondt F; Verschuere E; Vanhaute C; Tuytten R; Vanneste L; De Cremer K; Wuyts J; Davies H; Moerman P; Logeart D; Collet C; Lortat-Jacob B; Tavares M; Laroy W; Januzzi JL; Samuel JL; Kas K
Eur Heart J; 2012 Sep; 33(18):2317-24. PubMed ID: 22733835
[TBL] [Abstract][Full Text] [Related]
10. QSOX1, a novel actor of cardiac protection upon acute stress in mice.
Caillard A; Sadoune M; Cescau A; Meddour M; Gandon M; Polidano E; Delcayre C; Da Silva K; Manivet P; Gomez AM; Cohen-Solal A; Vodovar N; Li Z; Mebazaa A; Samuel JL
J Mol Cell Cardiol; 2018 Jun; 119():75-86. PubMed ID: 29723491
[TBL] [Abstract][Full Text] [Related]
11. Overcoming a species-specificity barrier in development of an inhibitory antibody targeting a modulator of tumor stroma.
Grossman I; Ilani T; Fleishman SJ; Fass D
Protein Eng Des Sel; 2016 Apr; 29(4):135-47. PubMed ID: 26819240
[TBL] [Abstract][Full Text] [Related]
12. Molecular Inhibitor of QSOX1 Suppresses Tumor Growth
Fifield AL; Hanavan PD; Faigel DO; Sergienko E; Bobkov A; Meurice N; Petit JL; Polito A; Caulfield TR; Castle EP; Copland JA; Mukhopadhyay D; Pal K; Dutta SK; Luo H; Ho TH; Lake DF
Mol Cancer Ther; 2020 Jan; 19(1):112-122. PubMed ID: 31575656
[TBL] [Abstract][Full Text] [Related]
13. Quiescin sulfhydryl oxidase 1 (QSOX1) glycosite mutation perturbs secretion but not Golgi localization.
Horowitz B; Javitt G; Ilani T; Gat Y; Morgenstern D; Bard FA; Fass D
Glycobiology; 2018 Aug; 28(8):580-591. PubMed ID: 29757379
[TBL] [Abstract][Full Text] [Related]
14.
Tong Y; Gibaut QMR; Rouse W; Childs-Disney JL; Suresh BM; Abegg D; Choudhary S; Akahori Y; Adibekian A; Moss WN; Disney MD
J Am Chem Soc; 2022 Jul; 144(26):11620-11625. PubMed ID: 35737519
[TBL] [Abstract][Full Text] [Related]
15. The emerging role of QSOX1 in cancer.
Lake DF; Faigel DO
Antioxid Redox Signal; 2014 Jul; 21(3):485-96. PubMed ID: 24359107
[TBL] [Abstract][Full Text] [Related]
16. Elevated transcription of the gene QSOX1 encoding quiescin Q6 sulfhydryl oxidase 1 in breast cancer.
Soloviev M; Esteves MP; Amiri F; Crompton MR; Rider CC
PLoS One; 2013; 8(2):e57327. PubMed ID: 23460839
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies against tissue-nonspecific alkaline phosphatase. Report of the ISOBM TD9 workshop.
Magnusson P; Arlestig L; Paus E; Di Mauro S; Testa MP; Stigbrand T; Farley JR; Nustad K; Millán JL
Tumour Biol; 2002; 23(4):228-48. PubMed ID: 12499779
[TBL] [Abstract][Full Text] [Related]
18. A secreted disulfide catalyst controls extracellular matrix composition and function.
Ilani T; Alon A; Grossman I; Horowitz B; Kartvelishvily E; Cohen SR; Fass D
Science; 2013 Jul; 341(6141):74-6. PubMed ID: 23704371
[TBL] [Abstract][Full Text] [Related]
19. A new strategy for the development of monoclonal antibodies for the determination of human procalcitonin in serum samples.
Kremmer E; Meyer K; Grässer FA; Flatley A; Kösters M; Luppa PB; Krämer PM
Anal Bioanal Chem; 2012 Jan; 402(2):989-95. PubMed ID: 22006244
[TBL] [Abstract][Full Text] [Related]
20. QSOX1 expression is associated with aggressive tumor features and reduced survival in breast carcinomas.
Knutsvik G; Collett K; Arnes J; Akslen LA; Stefansson IM
Mod Pathol; 2016 Dec; 29(12):1485-1491. PubMed ID: 27562495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
